A detailed history of Edge Rock Capital LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Edge Rock Capital LLC holds 3,529 shares of MRK stock, worth $339,877. This represents 0.29% of its overall portfolio holdings.

Number of Shares
3,529
Previous 3,007 17.36%
Holding current value
$339,877
Previous $372,000 7.53%
% of portfolio
0.29%
Previous 0.3%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$111.15 - $128.97 $58,020 - $67,322
522 Added 17.36%
3,529 $400,000
Q2 2024

Jul 24, 2024

BUY
$123.8 - $132.96 $67,223 - $72,197
543 Added 22.04%
3,007 $372,000
Q1 2024

May 15, 2024

BUY
$113.24 - $131.95 $11,097 - $12,931
98 Added 4.14%
2,464 $325,000
Q4 2023

Feb 06, 2024

BUY
$100.18 - $109.02 $27,950 - $30,416
279 Added 13.37%
2,366 $257,000
Q3 2023

Nov 14, 2023

BUY
$102.95 - $114.33 $214,856 - $238,606
2,087 New
2,087 $214,000
Q3 2022

Oct 14, 2022

BUY
$84.53 - $94.96 $29,162 - $32,761
345 New
345 $30,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $244B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Edge Rock Capital LLC Portfolio

Follow Edge Rock Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Edge Rock Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Edge Rock Capital LLC with notifications on news.